Jan 2022: Pembrolizumab (Keytruda, Merck) waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka ee daawaynta kaaliyaha ah ee bukaanada qaba kansarka unugyada kelyaha (RCC) kuwaas oo ku jira dhexdhexaad-sare ama khatar sare oo soo noqoshada ka dib ..
Ogosto 2021: Isku-darka lenvatinib (Lenvima, Eisai) iyo pembrolizumab (Keytruda, Merck) waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka si loo daweeyo safka koowaad ee bukaannada qaangaarka ah ee qaba kansarka unugyada kelyaha ee horumarsan.
Ogosto 2021: Tivozanib (Fotivda, AVEO Pharmaceuticals, Inc.), inhibitor kinase ah, ayaa FDA u oggolaatay bukaanada qaangaarka ah ee soo noqnoqda ama kansarka unugyada kelyaha ee horumarsan (RCC) kadib laba ama in ka badan nidaam hore.
Many patients with kidney cancer do not know why they have this disease, meaning the causes of kidney cancer are relatively unknown. After the examination, they will be very surprised. Some even feel that the kidney is not a probl..